A nurse-led paediatric oncology fast-track clinic proves a successful ambulatory intervention for patients.

Autor: Wong A; The Children's Cancer Centre, The Royal Children's Hospital, Melbourne, Australia., Glogolia M; The Children's Cancer Centre, The Royal Children's Hospital, Melbourne, Australia., Lange PW; Department of Medicine, Melbourne University, Melbourne, Australia., Dale S; The Children's Cancer Centre, The Royal Children's Hospital, Melbourne, Australia., Chappell M; The Children's Cancer Centre, The Royal Children's Hospital, Melbourne, Australia., Soosay Raj T; The Children's Cancer Centre, The Royal Children's Hospital, Melbourne, Australia., Hanna D; The Children's Cancer Centre, The Royal Children's Hospital, Melbourne, Australia., Devaraja L; Department of Paediatrics, Melbourne University, Melbourne, Australia., Williams C; The Children's Cancer Centre, The Royal Children's Hospital, Melbourne, Australia.; The Paediatric Integrated Cancer Service (PICS), Melbourne, Australia., Williamson J; The Paediatric Integrated Cancer Service (PICS), Melbourne, Australia., Conyers R; The Children's Cancer Centre, The Royal Children's Hospital, Melbourne, Australia. Rachel.conyers@rch.org.au.; Department of Paediatrics, Melbourne University, Melbourne, Australia. Rachel.conyers@rch.org.au.; Murdoch Children's Research Institute, Melbourne, Australia. Rachel.conyers@rch.org.au.
Jazyk: angličtina
Zdroj: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2020 Sep; Vol. 28 (9), pp. 4395-4403. Date of Electronic Publication: 2020 Jan 09.
DOI: 10.1007/s00520-019-05250-w
Abstrakt: Aim: To assess the impact of a pilot nurse-led paediatric oncology fast-track clinic (OFTC) for complications and side effects following chemotherapy within a paediatric tertiary hospital.
Methods: Prospective clinical data from the first 100 patients seen in the OFTC were compared with retrospective data of oncology patient presentations to the emergency department (ED) (over a 1-year period, n = 196) who would have been eligible for review in the OFTC. Parent and patient satisfaction of clinical care were also assessed via surveys pre- and post-OFTC implementation.
Results: Analysis which achieved statistical difference was a reduction in the number of blood tubes taken in OFTC (average 1.9 for those discharged from clinic, 2.9 for those admitted from clinic) in comparison to those seen in the ED (average 3.2) (p = 0.0027). The average number of interventions per patient seen in the ED were 2.1 (standard deviation 1.64) compared with 1.7 (standard deviation 1.55) interventions per patient seen in the OFTC, and who were not admitted following review. This result approached statistical significance with p = 0.0963. Other results which did not meet statistical significance included a reduction in treatment times, hospital admissions and medical oncology reviews.
Conclusion: Our pilot study implementing an OFTC for the triage and assessment of chemotherapy-related complications has proven successful from an operational and consumer perspective. The clinic improved care by ensuring expedited review, more streamlined interventions, and less overall hospital admissions. The improvements in efficiency were also mirrored by increased parent and patient satisfaction.
Databáze: MEDLINE